ECM
PLXP

ExodusPoint Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

ExodusPoint Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,758
Closed -$134K – 2812
2021
Q4 		$134K Buy
+16,758
New +$196K ﹤0.01% 1907

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

ExodusPoint Capital Management's PLXP Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2022, closing a stake of 16,758 shares — an estimated $134K sold.

ExodusPoint Capital Management first reported a position in PLXP in Q4 2021 and held it in 1 quarter. The position peaked at $134K in Q4 2021. 50 funds tracked by Wall St. Rank hold PLXP as of Q1 2022.

  • ExodusPoint Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 16,758 PLx Pharma Inc. Common Stock shares in Q1 2022, an estimated $134K.
  • ExodusPoint Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • ExodusPoint Capital Management's PLx Pharma Inc. Common Stock position peaked at $134K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.